Alice Emptoz

Title: Alice Emptoz: Innovator in Hearing Loss Treatment

Introduction

Alice Emptoz is a prominent inventor based in Paris, France. She has made significant contributions to the field of auditory health, particularly in the prevention and treatment of hearing loss and impairment. With a total of 2 patents, her work focuses on innovative solutions that leverage advanced biological mechanisms.

Latest Patents

Alice Emptoz's latest patents revolve around the use of gasdermin, specifically gasdermin A, B, C, D, DFNA5, and DFNB59 (or pejvakin). These inventions aim to modulate cellular redox homeostasis, with a particular emphasis on pejvakin as an antioxidant. Additionally, her research includes a virally-mediated gene therapy designed to restore genetically-impaired auditory and vestibular functions in individuals suffering from Usher syndrome. This gene therapy utilizes an AAV2/8 vector that expresses at least one USH1 gene product, preferably SANS.

Career Highlights

Throughout her career, Alice has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Clermont Auvergne. Her dedication to research and innovation has positioned her as a key figure in the scientific community focused on auditory health.

Collaborations

Alice Emptoz has collaborated with notable professionals in her field, including Paul Avan and Jean Defourny. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Alice Emptoz is a trailblazer in the realm of hearing loss treatment, with her innovative patents paving the way for future advancements in auditory health. Her work exemplifies the impact of dedicated research and collaboration in addressing critical health challenges.